Media
rainbow
Wednesday - February 25, 2015

Dr. Richard Pott to be Chairman of the Supervisory Board of Bayer MaterialScience

more imagesdownload
Dr. Richard Pott

Leverkusen, February 25, 2015 – At its meeting today, the Supervisory Board of Bayer AG agreed to the proposal made by the Board of Management of Bayer AG to appoint Dr. Richard Pott (61) to the Supervisory Board of Bayer MaterialScience AG effective March 26, 2015. It is intended that Dr. Pott should be elected as the new Chairman of the Supervisory Board of Bayer MaterialScience. In September 2014, Bayer announced its intention to float the MaterialScience business on the stock market by mid-2016 at the latest. Until now, Bayer Management Board member Werner Baumann has been the Chairman of the Supervisory Board of Bayer MaterialScience.

“We are pleased that Richard Pott is to be the Chairman of the Supervisory Board of Bayer MaterialScience. He is an experienced manager who knows the business very well,” said Bayer CEO Dr. Marijn Dekkers. “Within the context of the planned stock market listing, Bayer MaterialScience will be operating autonomously with a strategy that is distinct from Bayer's. I am confident that Richard Pott will contribute his expertise and foresight in collaborating closely with the Bayer MaterialScience Board of Management to shape the company's successful development.” Further members of the Supervisory Board are to be named ahead of the planned stock market listing of Bayer MaterialScience.

Dr. Richard Pott is a member of the supervisory boards of Freudenberg SE and Schott AG. He is also Chairman of the University Council of the University of Cologne. From 2002 to 2013, he served as a member of the Board of Management of Bayer AG with responsibility for Strategy and Human Resources. He was the company's Labor Director and responsible for the Americas, Africa and Middle East regions.

Note to editors:
A print-quality photo can be downloaded from our website at www.news.bayer.com.

Find more information at www.bayer.com.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.